Cell type | Treatment | Observer 1 t0 | Observer 1 t1 | Intra-observer comparison | Observer 2 | Observer 3 | Inter- observer comparison | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  | Placebo | Prednisolone | P a | Placebo | Prednisolone | P a | P b | Placebo | Prednisolone | P a | Placebo | Prednisolone | P a | Pc |
CD3+ T lymphocytes | Before | 192 ± 246 | 358 ± 413 | <0.05 | 110 ± 140 | 227 ± 225 | <0.05 | NS | 179 ± 185 | 285 ± 250 | <0.05 | 89 ± 110 | 112 ± 98 | <0.05 | NS |
 | After | 387 ± 391 | 140 ± 150 |  | 299 ± 356 | 44 ± 62 |  |  | 470 ± 618 | 101 ± 94 |  | 196 ± 224 | 54 ± 66 |  |  |
CD38+ plasma cells | Before | 56 ± 87 | 99 ± 130 | NS | 73 ± 134 | 116 ± 166 | NS | NS | 246 ± 307 | 397 ± 498 | NS | 145 ± 151 | 309 ± 380 | NS | NS |
 | After | 96 ± 127 | 37 ± 57 |  | 119 ± 149 | 42 ± 78 |  |  | 335 ± 411 | 132 ± 187 |  | 315 ± 416 | 83 ± 121 |  |  |
CD68+ macrophages | Before | 804 ± 422 | 973 ± 419 | <0.03 | 441 ± 422 | 572 ± 404 | <0.03 | NS | 937 ± 292 | 1151 ± 254 | <0.03 | 621 ± 445 | 724 ± 360 | <0.03 | NS |
 | After | 972 ± 151 | 553 ± 342 |  | 632 ± 686 | 222 ± 278 |  |  | 984 ± 354 | 796 ± 306 |  | 720 ± 527 | 313 ± 291 |  |  |